Lv11
90 积分 2020-10-21 加入
Optimizing the Design and Geometry of T Cell–Engaging Bispecific Antibodies Targeting CEA in Colorectal Cancer
3小时前
已完结
Genetically engineered brain drug delivery vectors: cloning, expression and in vivo application of an anti-transferrin receptor single chain antibody–streptavidin fusion gene and protein
1个月前
已完结
Budesonide delayed-release capsules to reduce proteinuria in adults with primary immunoglobulin A nephropathy
1个月前
已完结
Atrasentan in Patients with IgA Nephropathy
1个月前
已完结
Zibotentan in combination with dapagliflozin compared with dapagliflozin in patients with chronic kidney disease (ZENITH-CKD): a multicentre, randomised, active-controlled, phase 2b, clinical trial
1个月前
已完结
Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial
1个月前
已完结
Characterization of anti-CD3 antibodies in clinically available bispecific T cell engagers
2个月前
已完结
Clinical Pharmacology and Translational Science Considerations in the Development of Dual‐Payload Antibody Drug Conjugates
2个月前
已完结
An electrochemical surface plasmon resonance imaging system targeting cell analysis
3个月前
已完结
A novel antagonist anti‐cMet antibody with antitumor activities targeting both ligand‐dependent and ligand‐independent c‐Met receptors
4个月前
已完结